Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Vensica Therapeutics Inks Strategic Partnership with Merz

Wednesday, August 11, 2021

Vensica Therapeutics a clinical stage biopharmaceutical company announced that it has signed a strategic collaboration agreement with Merz Therapeutics a business of the Merz Group and a leader in the field of neurotoxins Vensica has licensed Merzs b...

Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture

Tuesday, August 10, 2021

To address the ongoing demand for COVID testing and to catalyze safe return of the workforce Dalrada Corporation is excited to announce that its subsidiary Dalrada Health entered into a joint venture partnership with Vivera Pharmaceutical Inc Vivera...

Fulgent Genetics Announces Acquisition of CSI Laboratories

Tuesday, August 10, 2021

Fulgent Genetics Inc a technologybased genetic testing company focused on transforming patient care in oncology infectious and rare diseases and reproductive health today announced that it has acquired CSI Laboratories CSI to expand its presence in s...

Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China

Monday, August 09, 2021

Epizyme Inc a fully integrated commercialstage biopharmaceutical company developing and delivering novel epigenetic therapies and HUTCHMED China Limited today announce a collaboration to research develop manufacture and commercialize TAZVERIK in Grea...

Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer

Friday, August 06, 2021

Kite a Gilead Company and Appia Bio Inc an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells HSCs for cancer patients today announced a collaboration and license agreement to research and...

Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP

Friday, August 06, 2021

Amring Pharmaceuticals Inc a niche generic and brand pharmaceutical company announced today that it has received FDA approval for generic Isoproterenol Hydrochloride USP mgmL available as mL or mL SingleDose Vials AP rated generic equivalent of Is...

BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland

Thursday, August 05, 2021

BioNTech SE and Kite a Gilead Company announced the closing of the acquisition of the solid tumor neoantigen T cell receptor TCR RD platform and clinical manufacturing facilitys assets and leases in Gaithersburg MD from Kite The transaction was annou...

EQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative Medicines

Thursday, August 05, 2021

EQRx a company committed to developing and delivering important new medicines at radically lower prices and AbCellera a technology company with a centralized operating system for nextgeneration antibody discovery today announced a collaboration agree...

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development

Wednesday, August 04, 2021

As part of Sanofis endeavor to accelerate the application of messenger RNA mRNA to develop therapeutics and vaccines the company has entered into a definitive agreement with Translate Bio a clinicalstage mRNA therapeutics company under which Sanofi w...

Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion Diagnostics Development

Wednesday, August 04, 2021

Burning Rock Biotech Limited announced a global strategic partnership with IMPACT Therapeutics in companion diagnostics CDx development for a pipeline of drugs in the field of synthetic lethality The two companies will jointly develop CDx for a targe...